Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 7/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA5A | P35218 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15747016 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL1726948 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL17724779 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL20033571 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL17192718 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL18105805 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL15040789 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL414930 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL8515524 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN | |
| SCHEMBL19304535 | 1.00 | CYP2D6 (0.59) | CYP2D6THRBHSD17B10NR3C1FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023098650-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | 盖鑫 | 2023-06-08 | — | — | WO | claimed |
| EP-3487318-B1 | GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS | PEPSICO INC (US) | 2026-04-01 | — | — | EP | disclosed |
| US-12552823-B2 | Glucosamine derivatives and pharmaceutical uses thereof | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2026-02-17 | — | — | US | disclosed |
| US-20250353870-A1 | GLUCOSAMINE DERIVATIVES AND PHARMACEUTICAL USES THEREOF | RISEN SUZHOU PHARMA TECH CO LTD (CN) | 2025-11-20 | — | — | US | disclosed |
| US-12312378-B2 | Glucosamine derivatives for the prevention or treatment of joint disorders | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2025-05-27 | — | — | US | disclosed |
| US-20250049831-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | GE, XIN (CN) | 2025-02-13 | — | — | US | disclosed |
| EP-4442262-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | Ge, Xin (CN) | 2024-10-09 | — | — | EP | disclosed |
| WO-2024044536-A2 | TUMOR-SEEKING GLUCOSE-DENDRONS FOR THE DELIVERY OF CHEMOTHERAPEUTICS AND IMAGING AGENT TO CANCER CELLS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-02-29 | — | — | WO | disclosed |
| US-20240051982-A1 | GLUCOSAMINE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF JOINT DISORDERS | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2024-02-15 | — | — | US | disclosed |
| US-11718636-B2 | Glucosamine derivatives for the prevention or treatment of joint disorders | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2023-08-08 | — | — | US | disclosed |
| US-20140315255-A1 | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | ALBANY MOLECULAR RESEARCH, INC. (US) | 2014-10-23 | — | — | US | disclosed |
| US-8754054-B2 | Antibacterial compounds, methods of making them, and uses thereof | ALBANY MOLECULAR RESEARCH, INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-20130237490-A2 | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | ALBANY MOLECULAR RESEARCH, INC. (US) | 2013-09-12 | — | — | US | disclosed |
| US-20120010163-A1 | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-01-12 | — | — | US | disclosed |
| WO-2012006321-A2 | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| EP-1955601-A1 | Use of propenylphenylglycosides for intensifying sweet sensory impressions | Symrise GmbH & Co. KG (DE) | 2008-08-13 | — | — | EP | disclosed |
| EP-1448644-A2 | MATRIX FOR SOLID-PHASE ORGANIC SYNTHESIS | Carlsberg A/S (DK) | 2004-08-25 | — | — | EP | disclosed |
| WO-2003031489-A2 | MATRIX FOR SOLID-PHASE ORGANIC SYNTHESIS | CARLSBERG A/S (DK) | 2003-04-17 | — | — | WO | disclosed |
| US-5563259-A | NONCATALYTIC REACTION; PURITY | PFIZER INC. (US) | 1996-10-08 | — | — | US | disclosed |
| US-5298616-A | Sulfated O-polysaccharide-trehaloses | HOFFMANN-LA ROCHE INC. (US) | 1994-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140315255-A1 | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | NRDC, VIP, LPO | CYP2D6 3934/4885THRB 2948/4885HSD17B10 1475/4885 |
| US-20250353870-A1 | GLUCOSAMINE DERIVATIVES AND PHARMACEUTICAL USES THEREOF | OGT, UGGT1, GLA | CYP2D6 625/4885THRB 1526/4885HSD17B10 3004/4885 |
| US-20240051982-A1 | GLUCOSAMINE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF JOINT DISORDERS | OGT, UGGT1, FUT6 | CYP2D6 1398/4885THRB 2091/4885HSD17B10 2371/4885 |
| US-20120010163-A1 | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | NRDC, VIP, LPO | CYP2D6 3934/4885THRB 2948/4885HSD17B10 1475/4885 |
| US-11718636-B2 | Glucosamine derivatives for the prevention or treatment of joint disorders | OGT, UGGT1, GLA | CYP2D6 1758/4885THRB 1546/4885HSD17B10 2376/4885 |
| US-20130237490-A2 | NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF | NRDC, VIP, LPO | CYP2D6 3934/4885THRB 2948/4885HSD17B10 1475/4885 |
| US-20250049831-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | ACE2, LBR, YWHAZ | CYP2D6 1077/4885THRB 1900/4885HSD17B10 2699/4885 |
| US-12552823-B2 | Glucosamine derivatives and pharmaceutical uses thereof | SOST, FUT6, SLC5A1 | CYP2D6 1419/4885THRB 819/4885HSD17B10 4261/4885 |
| US-12312378-B2 | Glucosamine derivatives for the prevention or treatment of joint disorders | OGT, UGGT1, FUT6 | CYP2D6 1398/4885THRB 2091/4885HSD17B10 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.